General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(SIGNIFICANT), Agepha(SIGNIFICANT), AstraZeneca(MODEST), Novo Nordisk Inc.(SIGNIFICANT), New Amstrerdam, Inc(SIGNIFICANT), Cardio Therapeutics(SIGNIFICANT), Pfizer Inc(SIGNIFICANT), SOCAR(SIGNIFICANT), Leducq Foundation(SIGNIFICANT), Lilly(SIGNIFICANT), Nodthera(SIGNIFICANT), Caristo(MODEST), Tourmaline Bio(SIGNIFICANT), Merck(MODEST), CSL Behring (MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Uppton, Ltd(NONE), Angiowave, Inc(NONE) RESEARCH/RESEARCH GRANTS: Novartis(SIGNIFICANT), National Heart Lung and Blood Institute (NHLBI)(SIGNIFICANT), Kowa Pharmaceuticals (SIGNIFICANT), Amarin(SIGNIFICANT)

View Full Disclosure